Aesica selects Buck valve technology from GEA Pharma Systems

Leading pharmaceutical manufacturer, Aesica, has chosen Buck split butterfly valves from GEA Pharma Systems for the contained transfer of potent powders at its new purpose-built, high-containment facility at its Queenborough site.

The new facility will include suites for blending, tabletting and blister packing along with appropriate HVAC, analytical and cleaning facilities. It will be completely separate from the rest of the company's manufacturing facilities to prevent any potential cross-contamination.

The Buck® MC (Modular Containment) Valve from GEA Pharma Systems Buck® offers inspired technology with a number of key additional features and benefits over the current generation of split butterfly valves, including:

•Unique passive-to-passive valve design with a centralised actuation collar.

•The passive valves are freely orientating reducing operator docking error.

•Modular Containment: The Buck® MC valve has 1-10 µg/m³ containment level as standard. The system can, however, easily be upgraded with the advanced air cleaning actuator to further improve containment levels to
Companies in this article
More in Home